RPS6KA1 and pancreatic neoplasm: In summary, these data suggest that Rapamycin affects the translation of mRNAs in a specific manner in pancreatic cancer cells that lack 4EBP1 expression likely through phospho-AKT and/or phospho-p90-RSK1 activation.